Tumor Ablation Market

Tumor Ablation Market (Technology - Radiofrequency Ablation, Microwave Ablation, Cryoablation, High-Intensity Focused Ultrasound, and Laser Interstitial Thermal Ablation; Disease Indication - Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, and Prostate Cancer; End Users - Hospitals and Cancer Specialty Clinics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

  • Rep Id : TMRGL18656
  • Published On : Mar 2018
  • No. of Pages : 165
  • Category : Healthcare

1. Preface

2. Research Methodology & Assumptions

3. Executive Summary

4. Global Tumor Ablation Products Market Overview
     4.1 Introduction (Product Definition)
     4.2 Industry Evolution/Development 
     4.3 Key Market Indicators
     4.4 Market Dynamics
           4.4.1 Drivers
           4.4.2 Restraints
           4.4.3 Opportunity
     4.5 Global Market Analysis and Forecasts, 2014 – 2024
     4.6 Global Market - Global Supply Demand Scenario
     4.7 Porter’s Five Force Analysis
     4.8 Value Chain Analysis
     4.9 Market Outlook

5. Global Tumor Ablation Market Analysis and Forecast by Technology
     5.1 Key Findings
     5.2 Introduction
     5.3 Market Size (US$ Mn) Forecast, By Technology
           5.3.1 Radiofrequency Ablation
           5.3.2 Microwave Ablation
           5.3.3 Cryoablation
           5.3.4 High-Intensity Focused Ultrasound
           5.3.5 Laser Interstitial Thermal Ablation
           5.3.6 Others
     5.4 Market Attractiveness, By Technology
     5.5 Key Trends

6. Global Tumor Ablation Market Analysis and Forecast by Disease Indication
     6.1 Key Findings
     6.2 Introduction
     6.3 Market Size (US$ Mn) Forecast, By Disease Indication
           6.3.1 Liver cancer
           6.3.2 Lung cancer
           6.3.3 Kidney cancer
           6.3.4 Bone cancer
           6.3.5 Breast cancer
           6.3.6 Prostate cancer
           6.3.7 Others
     6.4 Market Attractiveness, By Disease Indication
     6.5 Key Trends

7. Global Tumor Ablation Market Analysis and Forecast by End User
     7.1 Key Findings
     7.2 Introduction
     7.3 Market Size (US$ Mn) Forecast, By End User
           7.3.1 Home Users
           7.3.2 Clinics
           7.3.3 Hospitals
     7.4 Market Attractiveness, By End User
     7.5 Key Trends

8. Global Tumor Ablation Market Analysis and Forecast by Region
     8.1 Key Findings
     8.2 Introduction
           8.2.1 Market Size (US$ Mn) Forecast, By Region
           8.2.2 North America
           8.2.3 Europe
           8.2.4 Asia Pacific
           8.2.5 Latin America
           8.2.6 Middle East and Africa

9. North America Tumor Ablation Market Analysis and Forecast by Region
     9.1 Key Findings
     9.2 North America Market Forecast, by Technology
     9.3 North America Market Forecast, by Disease Indication
     9.4 North America Market Forecast, by End User
     9.5 North America Market Forecast, by Country
           9.5.1 U.S. Market Overview
           9.5.2 Canada Market Overview
     9.6 North America Market Attractiveness Analysis
     9.7 Market Trends

10. Europe Tumor Ablation Market Analysis and Forecast by Region
     10.1 Key Findings
     10.2 Europe  Market Forecast, by Technology
     10.3 Europe Market Forecast, by Disease Indication
     10.4 Europe Market Forecast, by End User
     10.5 Europe Market Forecast, by Country
           10.5.1 U.K. Market Overview
           10.5.2 Germany Market Overview
           10.5.3 France Market Overview
           10.5.4 Italy Market Overview
           10.5.5 Spain Market Overview
           10.5.6 Russia Market Overview
           10.5.7 Rest of Europe Market Overview
     10.6 Europe Market Attractiveness Analysis
     10.7 Market Trends

11. Asia Pacific Tumor Ablation Market Analysis and Forecast by Region
     11.1 Key Findings
     11.2 Asia Pacific Market Forecast, by Technology
     11.3 Asia Pacific Market Forecast, by Disease Indication
     11.4 Asia Pacific Market Forecast, by End User
     11.5 Asia Pacific Market Forecast, by Country
           11.5.1 India Market Overview
           11.5.2 China Market Overview
           11.5.3 Japan  Market Overview
           11.5.4 Australia of Asia Pacific Tumor Ablation Market Overview
           11.5.5 Rest of APAC Tumor Ablation Market Overview
     11.6 Asia Pacific Market Attractiveness Analysis
     11.7 Market Trends

12 Latin America Tumor Ablation Market Analysis and Forecast by Region
     12.1 Key Findings
     12.2 Latin America Market Forecast, by Technology
     12.3 Latin America Market Forecast, by Disease Indication
     12.4 Latin America Market Forecast, by End User
     12.5 Latin America Market Forecast, by Country
           12.5.1 Brazil Tumor Ablation Market Overview
           12.5.2 Mexico Tumor Ablation Market Overview
           12.5.3 Rest of LATAM Tumor Ablation Market Overview
     12.6 Latin America Market Attractiveness Analysis
     12.7 Market Trends

13 Middle East and Africa Tumor Ablation Market Analysis and Forecast by Region
     13.1 Key Findings
     13.2 Middle East and Africa Market Forecast, by Technology
     13.3 Middle East and Africa Market Forecast, by Disease Indication
     13.4 Middle East and Africa Market Forecast, by End User
     13.5 Middle East and Africa Market Forecast, by Country
           13.5.1 South Africa Tumor Ablation Market Overview
           13.5.2 GCC countries Tumor Ablation Market Overview
           13.5.3 Rest of MEA Tumor Ablation Market Overview
     13.6 Middle East and Africa Market Attractiveness Analysis
     13.7 Market Trends

14. Competitive Landscape
     14.1 Market Share Analysis, by Company
     14.2 Competition Matrix
     14.3 Company Profiles
           14.3.1 Medtronic plc.
                    14.3.1.1 Company Details
                    14.3.1.2 Business Overview
                    14.3.1.3 Financial Overview
                    14.3.1.4 Strategic Overview
                    14.3.1.5 SWOT Analysis
           14.3.2 Integra LifeSciences Holdings Corporation
                    14.3.2.1 Company Details
                    14.3.2.2 Business Overview
                    14.3.2.3 Financial Overview
                    14.3.2.4 Strategic Overview
                    14.3.2.5 SWOT Analysis
           14.3.3 BTG International Ltd
                    14.3.3.1 Company Details
                    14.3.3.2 Business Overview
                    14.3.3.3 Financial Overview
                    14.3.3.4 Strategic Overview
                    14.3.3.5 SWOT Analysis
           14.3.4 Boston Scientific Corporation
                    14.3.4.1 Company Details
                    14.3.4.2 Business Overview
                    14.3.4.3 Financial Overview
                    14.3.4.4 Strategic Overview
                    14.3.4.5 SWOT Analysis
           14.3.5 AngioDynamics, Inc.
                    14.3.5.1 Company Details
                    14.3.5.2 Business Overview
                    14.3.5.3 Financial Overview
                    14.3.5.4 Strategic Overview
                    14.3.5.5 SWOT Analysis
           14.3.6 SonaCare Medical, LLC.
                    14.3.6.1 Company Details
                    14.3.6.2 Business Overview
                    14.3.6.3 Financial Overview
                    14.3.6.4 Strategic Overview
                    14.3.6.5 SWOT Analysis
           14.3.7 BVM Medical Limited
                    14.3.7.1 Company Details
                    14.3.7.2 Business Overview
                    14.3.7.3 Financial Overview
                    14.3.7.4 Strategic Overview
                    14.3.7.5 SWOT Analysis
           14.3.8 St. Jude Medical, Inc.
                    14.3.8.1 Company Details
                    14.3.8.2 Business Overview
                    14.3.8.3 Financial Overview
                    14.3.8.4 Strategic Overview
                    14.3.8.5 SWOT Analysis
           14.3.9 EDAP TMS S.A.
                    14.3.9.1 Company Details
                    14.3.9.2 Business Overview
                    14.3.9.3 Financial Overview
                    14.3.9.4 Strategic Overview
                    14.3.9.5 SWOT Analysis

List of Table

Table 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 02: Global Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 03: Global Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 04: Global Tumor Ablation Market Size (US$ Mn) Forecast, By Region Type, 2015–2024
Table 05: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 06: North America Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 07: North America Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 08: North America Tumor Ablation Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 09: Europe Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 10: Europe Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 11: Europe Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 12: Europe Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 13: Asia Pacific Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 14: Asia Pacific Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 15: Asia Pacific Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 16: Asia Pacific Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 17: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 18: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 19: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 20: Latin America Market Size (US$ Mn) Forecast, By Country, 2016–2024
Table 21: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By Technology, 2016–2024
Table 22: MEA Market Size (US$ Mn) Forecast, By Disease Indication, 2016–2024
Table 23: MEA Tumor Ablation Market Size (US$ Mn) Forecast, By End User, 2016–2024
Table 24: MEA Market Size (US$ Mn) Forecast, By Country, 2016–2024

List of Figures

Figure 01: Global Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 02: Global Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 03: Global Technology Market Revenue
Figure 04: Global Technology Market Revenue
Figure 05: Global Technology Market Revenue
Figure 06: Global Technology Market Revenue
Figure 07: Global Technology Market Revenue
Figure 08: Global Tumor Ablation Technology Market Revenue
Figure 09: Tumor Ablation Technology Market Attractiveness Analysis by Technology
Figure 10: Global Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 11: Global Tumor Ablation Disease Indication Market Revenue
Figure 12: Global Disease Indication Market Revenue
Figure 13: Global Disease Indication Market Revenue
Figure 14: Global Disease Indication Market Revenue
Figure 15: Global Disease Indication Market Revenue
Figure 16: Global Disease Indication Market Revenue
Figure 17: Global Disease Indication Market Revenue
Figure 18: Tumor Ablation Market Attractiveness Analysis by Disease Indication
Figure 19: Global Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 20: Global Home User Tumor Ablation Market Revenue
Figure 21: Global Clinics Tumor Ablation Market Revenue
Figure 22: Global Hospitals Tumor Ablation Market Revenue
Figure 23: Tumor Ablation Market Attractiveness Analysis by End User
Figure 24: Global Tumor Ablation Market Value Share Analysis by Region Type, 2016 and 2024
Figure 25: Tumor Ablation Market Attractiveness Analysis, By Region Type
Figure 26: North America Market Size (US$ Mn) Forecast, 2015–2024
Figure 27: North America Market Attractiveness Analysis by Country
Figure 28: North America Market Value Share Analysis by Technology, 2016 and 2024
Figure 29: North America Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 30: North America Market Value Share Analysis by End User, 2016 and 2024
Figure 31: North America Market Value Share Analysis by Country, 2016 and 2024
Figure 32: North America Market Attractiveness Analysis, By Disease Indication
Figure 33: North America Market Attractiveness Analysis, By Technology
Figure 34: North America Market Attractiveness Analysis, By End User
Figure 35: Europe Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 36: Europe Market Attractiveness Analysis by Country
Figure 37: Europe Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 38: Europe Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 39: Europe Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 40: Europe Market Value Share Analysis by Country, 2016 and 2024
Figure 41: Europe Market Attractiveness Analysis, By Disease Indication
Figure 42: Europe Market Attractiveness Analysis, By Technology
Figure 43: Europe Market Attractiveness Analysis, By End User
Figure 44: Asia Pacific Market Size (US$ Mn) Forecast, 2015–2024
Figure 45: Asia Pacific Market Attractiveness Analysis by Country
Figure 46: Asia Pacific Market Value Share Analysis by Technology, 2016 and 2024
Figure 47: Asia Pacific Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 48: Asia Pacific Market Value Share Analysis by End User, 2016 and 2024
Figure 49: Asia Pacific Market Value Share Analysis by Country, 2016 and 2024
Figure 50: Asia Pacific Market Attractiveness Analysis, By Disease Indication
Figure 51: Asia Pacific Market Attractiveness Analysis, By Technology
Figure 52: Asia Pacific Market Attractiveness Analysis, By End User
Figure 53: Latin America Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 54: Latin America Market Attractiveness Analysis by Country
Figure 55: Latin America Tumor Ablation Market Value Share Analysis by Technology, 2016 and 2024
Figure 56: Latin America Tumor Ablation Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 57: Latin America Tumor Ablation Market Value Share Analysis by End User, 2016 and 2024
Figure 58: Latin America Market Value Share Analysis by Country, 2016 and 2024
Figure 59: Latin America Market Attractiveness Analysis, By Disease Indication
Figure 60: Latin America Market Attractiveness Analysis, By Technology
Figure 61: Latin America Market Attractiveness Analysis, By End User
Figure 62: MEA Tumor Ablation Market Size (US$ Mn) Forecast, 2015–2024
Figure 63: MEA Market Attractiveness Analysis by Country
Figure 64: MEA  Market Value Share Analysis by Technology, 2016 and 2024
Figure 65: MEA Market Value Share Analysis by Disease Indication, 2016 and 2024
Figure 66: MEA Market Value Share Analysis by End User, 2016 and 2024
Figure 67: MEA Market Value Share Analysis by Country, 2016 and 2024
Figure 68: MEA Market Attractiveness Analysis, By Disease Indication
Figure 69: MEA Market Attractiveness Analysis, By Technology
Figure 70: MEA Market Attractiveness Analysis, By End User
Figure 71: Global Tumor Ablation Market Share Analysis by Company (2015)